18F-Fluorocholine for the Detection of Parathyroid Adenomas
| Status: | Recruiting |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 13 - Any |
| Updated: | 12/6/2018 |
| Start Date: | September 2016 |
| End Date: | December 2021 |
| Contact: | Maya Aslam |
| Email: | maya.aslam@ucsf.edu |
The investigators are studying the ability of F18 labeled fluorocholine PET to localize
parathyroid adenomas in patients with hyperparathyroidism prior to surgery.
parathyroid adenomas in patients with hyperparathyroidism prior to surgery.
Inclusion Criteria:
- Biochemically proven hyperparathyroidism and an indication for surgery
- Age ≥ 13 years
- Karnofsky performance status of > 50 (or ECOG/WHO equivalent).
- Ability to understand a written informed consent document, and the willingness to sign
it.
Exclusion Criteria:
- Patients exceeding the weight limitations of the scanner or are not able to enter the
bore of the PET scanner due to BMI.
- Inability to lie still for the entire imaging time (e.g. cough, severe arthritis,
etc.).
- Inability to complete the needed investigational due to other reasons (severe
claustrophobia, radiation phobia, etc.).
- Pregnancy.
We found this trial at
1
site
Click here to add this to my saved trials
